The John Cleland photo archive

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Spotlight article 

John Mark Cleland, the first man to be cured of metastatic testicular cancer, died Feb. 7, 2022 in Indianapolis. He was 71. 

This photo archive was compiled to honor Cleland’s storied life, including when he was a torchbearer for the 2002 Winter Olympics in Salt Lake City. Photos courtesy of Indiana University Simon Cancer Center. 

An obituary of Cleland appears here. A full photo archive appears here.


May 9 virtual panel 

Health Equity: Advocacy and access in the community

Join Karen Knudsen May 9 at 6 PM EST in conversation about health equity as it relates to working with communities and advocating for access to care.

Moderator

  • Karen Knudsen, MBA, PhD
    CEO, American Cancer Society and the American Cancer Society Cancer Action Network

Panelists

  • Clifford A. Hudis, MD
    CEO, American Society of Clinical Oncology; Executive vice chair, Conquer Cancer Foundation;
    Chair, CancerLinQ
  • Chanita Hughes Halbert, PhD
    Vice chair for research, professor, Department of Population and Public Health Sciences; Associate director for cancer equity, Norris Comprehensive Cancer Center, University of Southern California
  • Amy E. Leader, DrPH, MPH
    Associate professor of population science and medical oncology, associate director of community integration, Sidney Kimmel Cancer Center; Public health teaching faculty, College of Population Health, Thomas Jefferson University
  • Cheryl Willman, MD
    Executive director, Mayo Clinic Cancer Programs (nationally and globally); Director, Mayo Clinic Comprehensive Cancer Center

Register now


This column features the latest posts to the Cancer History Project by our growing list of contributors

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available. 

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj, or follow our podcast.

Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology. 

To apply to become a contributor, please contact admin@cancerhistoryproject.com.

Table of Contents

YOU MAY BE INTERESTED IN

Cell and gene therapies have made incredible strides over the past decade. The 2024 FDA approvals of the first T-cell receptor therapy for the treatment of metastatic synovial sarcoma and the first tumor-infiltrating lymphocyte therapy for the treatment of unresectable or metastatic melanoma mark a significant turning point for solid tumor treatment.xxx:more
The intersection of diabetes, obesity and cancer represents an important and underappreciated challenge in medicine. Apart from smoking, overweight is now the leading modifiable risk factor for cancer. With the global epidemic of overweight and diabetes driving cancer incidence across multiple organ sites, understanding the metabolic underpinnings of this relationship has never been more critical.
The Pazdurs in their garden with their dog, Cleo. The dog’s full name is Cleopatra, Queen of Denial.In 1999, Rick Pazdur went in for a “perfunctory” final interview at FDA. Thinking it would only take a few minutes, his wife, Mary, decided to wait and have a quick cup of coffee at a nearby restaurant—Hooters.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login